Patricia Quintana Bárcena - Search Results

Year	Number of Results
2011	1
2015	1
2017	1
2018	2
2019	2
2021	1
2022	1
2023	0

1

Domiciliary medication review (ReMeDo): development, reliability and acceptability of a tool for community pharmacists.

Quintana-Barcena P, Sinner C, Berger J. Quintana-Barcena P, et al. Int J Pharm Pract. 2022 May 26;30(2):129-135. doi: 10.1093/ijpp/riab078. Int J Pharm Pract. 2022. PMID: 34969087 Review.

2

Authors, peer reviewers, and readers: What is expected from each player in collaborative publishing?

Fernandez-Llimos F; Pharmacy Practice 2020 peer reviewers. Fernandez-Llimos F, et al. Pharm Pract (Granada). 2021 Jan-Mar;19(1):2284. doi: 10.18549/PharmPract.2021.1.2284. Epub 2021 Jan 14. Pharm Pract (Granada). 2021. PMID: 33520041 Free PMC article.

3

Beliefs influencing community pharmacists' interventions with chronic kidney disease patients: A theory-based qualitative study.

Quintana-Bárcena P, Lalonde L, Lauzier S. Quintana-Bárcena P, et al. Res Social Adm Pharm. 2019 Feb;15(2):145-153. doi: 10.1016/j.sapharm.2018.04.004. Epub 2018 Apr 6. Res Social Adm Pharm. 2019. PMID: 29709530

4

Clinical Pharmacy Activities Documented (ClinPhADoc): Development, Reliability and Acceptability of a Documentation Tool for Community Pharmacists.

Hamada N, Quintana Bárcena P, Maes KA, Bugnon O, Berger J. Hamada N, et al. Among authors: quintana barcena p. Pharmacy (Basel). 2019 Dec 2;7(4):162. doi: 10.3390/pharmacy7040162. Pharmacy (Basel). 2019. PMID: 31810295 Free PMC article.

5

Prevalence and Management of Drug-Related Problems in Chronic Kidney Disease Patients by Severity Level: A Subanalysis of a Cluster Randomized Controlled Trial in Community Pharmacies.

Quintana-Bárcena P, Lord A, Lizotte A, Berbiche D, Lalonde L. Quintana-Bárcena P, et al. J Manag Care Spec Pharm. 2018 Feb;24(2):173-181. doi: 10.18553/jmcp.2018.24.2.173. J Manag Care Spec Pharm. 2018. PMID: 29384023 Clinical Trial.

6

Community Pharmacist Training-and-Communication Network and Drug-Related Problems in Patients With CKD: A Multicenter, Cluster-Randomized, Controlled Trial.

Lalonde L, Quintana-Bárcena P, Lord A, Bell R, Clément V, Daigneault AM, Legris MÈ, Letendre S, Mouchbahani M, Jouini G, Azar J, Martin É, Berbiche D, Beaulieu S, Beaunoyer S, Bertin É, Bouvrette M, Charbonneau-Séguin N, Desrochers JF, Desforges K, Dumoulin-Charette A, Dupuis S, El Bouchikhi M, Forget R, Guay M, Lemieux JP, Morin-Bélanger C, Noël I, Ricard S, Sauvé P, Ste-Marie Paradis F. Lalonde L, et al. Among authors: quintana barcena p. Am J Kidney Dis. 2017 Sep;70(3):386-396. doi: 10.1053/j.ajkd.2017.05.008. Epub 2017 Jun 26. Am J Kidney Dis. 2017. PMID: 28663062 Clinical Trial.

7

Development and validation of criteria for classifying severity of drug-related problems in chronic kidney disease: A community pharmacy perspective.

Quintana-Bárcena P, Lord A, Lizotte A, Berbiche D, Jouini G, Lalonde L. Quintana-Bárcena P, et al. Am J Health Syst Pharm. 2015 Nov 1;72(21):1876-84. doi: 10.2146/ajhp140765. Am J Health Syst Pharm. 2015. PMID: 26490822

8

Development and validation of the PAIR (Pharmacotherapy Assessment in Chronic Renal Disease) criteria to assess medication safety and use issues in patients with CKD.

Desrochers JF, Lemieux JP, Morin-Bélanger C, Paradis FS, Lord A, Bell R, Berbiche D, Bárcena PQ, Séguin NC, Desforges K, Legris MÈ, Sauvé P, Lalonde L. Desrochers JF, et al. Among authors: barcena pq. Am J Kidney Dis. 2011 Oct;58(4):527-35. doi: 10.1053/j.ajkd.2011.04.020. Epub 2011 Jul 20. Am J Kidney Dis. 2011. PMID: 21778005 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results